Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma
Joshua B.N. Dawkins, Jun Wang, Eleni Maniati, et al.
Cancer Research (2016) Vol. 76, Iss. 16, pp. 4861-4871
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Biological effects of radiation on cancer cells
Jinsong Wang, Haijuan Wang, Haili Qian
Military Medical Research (2018) Vol. 5, Iss. 1
Open Access | Times Cited: 210
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Akimasa Hayashi, Jun Fan, Ruoyao Chen, et al.
Nature Cancer (2020) Vol. 1, Iss. 1, pp. 59-74
Open Access | Times Cited: 168
Clinical cancer immunotherapy: Current progress and prospects
Chenglong Liu, Mengxuan Yang, Daizhou Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 155
NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
Zuolei Jing, Qianmei Liu, Xinyuan He, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 83
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
Shilpa S. Dhar, Dongyu Zhao, Tao Lin, et al.
Molecular Cell (2018) Vol. 70, Iss. 5, pp. 825-841.e6
Open Access | Times Cited: 139
Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
Shidong Lv, Liyan Ji, Bin Chen, et al.
Oncogene (2017) Vol. 37, Iss. 10, pp. 1354-1368
Open Access | Times Cited: 109
The role of histone methylation in the development of digestive cancers: a potential direction for cancer management
Yuan Chen, Bo Ren, Jinshou Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 107
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer
Jia Lv, Yongze Zhu, Alin Ji, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 93
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis
Enrique Lin-Shiao, Yemin Lan, Mariel Coradin, et al.
Genes & Development (2018) Vol. 32, Iss. 2, pp. 181-193
Open Access | Times Cited: 92
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
Yuanwang Pan, Han Han, Hai Hu, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 88-105.e8
Open Access | Times Cited: 48
Integrated molecular characterization of IDH‐mutant glioblastomas
Andrey Korshunov, Belén Casalini, Lukas Chávez, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 2, pp. 108-118
Closed Access | Times Cited: 78
Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming
Μαρίνα Κουτσιούμπα, Maria Hatziapostolou, Christos Polytarchou, et al.
Gut (2018) Vol. 68, Iss. 7, pp. 1271-1286
Open Access | Times Cited: 70
Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
Shilpa S. Dhar, Min Gyu Lee
Oncotarget (2021) Vol. 12, Iss. 13, pp. 1296-1308
Open Access | Times Cited: 42
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis
Tanja Limberger, Michaela Schlederer, Karolína Trachtová, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 36
LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors
Ganesan Arunkumar, Shankar Anand, Partha Raksha, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 58
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets
Leah Gates, Guowei Gu, Yue Chen, et al.
Oncogene (2018) Vol. 37, Iss. 33, pp. 4581-4598
Open Access | Times Cited: 53
Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance
Abakundana Nsenga Ariston Gabriel, Qinlian Jiao, Yvette Umwali, et al.
Pancreatology (2019) Vol. 20, Iss. 1, pp. 79-88
Open Access | Times Cited: 47
Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway
Fan Yang, Yunfeng Zheng, Qiong Luo, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Deep learning-based multi-modal data integration enhancing breast cancer disease-free survival prediction
Zehua Wang, Ruichong Lin, Yanchun Li, et al.
Precision Clinical Medicine (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 5
Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer
Xiaoqing Chen, Guochun Zhang, Bo Chen, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 116, pp. 108997-108997
Open Access | Times Cited: 41
WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage
Beth K. Neilsen, Binita Chakraborty, Jamie L. McCall, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 39
Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer
Wenjun Xiong, Zhenxuan Deng, Yuxin Tang, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 504, Iss. 1, pp. 129-136
Closed Access | Times Cited: 39
A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination
Noboru Ideno, Hiroshi Yamaguchi, Takashi Okumura, et al.
Laboratory Investigation (2019) Vol. 99, Iss. 8, pp. 1233-1244
Open Access | Times Cited: 37
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
Yang Liu, Mingli Jin, Kwang Won Jeong
Biology (2021) Vol. 10, Iss. 7, pp. 581-581
Open Access | Times Cited: 28
NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1
Zuolei Jing, Qianmei Liu, Wanlin Xie, et al.
Cellular Signalling (2022) Vol. 92, pp. 110265-110265
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top